FDA 483 - August Bioservices LLC - April 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
August Bioservices, LLC, a sterile drug manufacturer in Nashville, TN, was cited for significant deficiencies in its quality systems. Observations included inadequate investigations into environmental monitoring excursions and particle defects, failures in good documentation practices and deviation management, and disorderly storage of materials. These issues indicate a lack of thoroughness in quality control and adherence to established procedures, potentially impacting product quality and patient safety.
ID · 9fb5a5b0-1372-4bbc-b62d-0e05b0edf3e5